These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17530729)

  • 21. MALDI-TOF mass-spectrometry-based versatile method for the characterization of protein kinases.
    Kondo N; Nishimura S
    Chemistry; 2009; 15(6):1413-21. PubMed ID: 19115309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of 2-amino-4-(7-azaindol-3-yl)pyrimidines as cyclin dependent kinase 1 (CDK1) inhibitors.
    Huang S; Li R; Connolly PJ; Emanuel S; Middleton SA
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4818-21. PubMed ID: 16870444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel aminomethylindole derivatives as inhibitors of pp60c-Src tyrosine kinase: synthesis and biological activity.
    Işgör YG; Kiliç Z; Olgen S
    Chem Biol Drug Des; 2008 Dec; 72(6):599-604. PubMed ID: 19090928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold.
    Zhao A; Gao X; Wang Y; Ai J; Wang Y; Chen Y; Geng M; Zhang A
    Bioorg Med Chem; 2011 Jul; 19(13):3906-18. PubMed ID: 21665484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and utilization of chiral alpha-methylated alpha-amino acids with a carboxyalkyl side chain in the design of novel Grb2-SH2 peptide inhibitors free of phosphotyrosine.
    Long YQ; Xue T; Song YL; Liu ZL; Huang SX; Yu Q
    J Med Chem; 2008 Oct; 51(20):6371-80. PubMed ID: 18821748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectroscopic characterization of the SH2- and active site-directed peptide sequences of a bivalent Src kinase inhibitor.
    Desamero RZ; Kang J; Dol C; Chinwong J; Walters K; Sivarajah T; Profit AA
    Appl Spectrosc; 2009 Jul; 63(7):767-74. PubMed ID: 19589214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.
    Lin LG; Xie H; Li HL; Tong LJ; Tang CP; Ke CQ; Liu QF; Lin LP; Geng MY; Jiang H; Zhao WM; Ding J; Ye Y
    J Med Chem; 2008 Aug; 51(15):4419-29. PubMed ID: 18610999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.
    Gracias V; Ji Z; Akritopoulou-Zanze I; Abad-Zapatero C; Huth JR; Song D; Hajduk PJ; Johnson EF; Glaser KB; Marcotte PA; Pease L; Soni NB; Stewart KD; Davidsen SK; Michaelides MR; Djuric SW
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2691-5. PubMed ID: 18362070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors.
    Ni Y; Gopalsamy A; Cole D; Hu Y; Denny R; Ipek M; Liu J; Lee J; Hall JP; Luong M; Telliez JB; Lin LL
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5952-6. PubMed ID: 21862328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities.
    Fallah-Tafti A; Tiwari R; Shirazi AN; Akbarzadeh T; Mandal D; Shafiee A; Parang K; Foroumadi A
    Med Chem; 2011 Sep; 7(5):466-72. PubMed ID: 21801146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases.
    Smaill JB; Baker EN; Booth RJ; Bridges AJ; Dickson JM; Dobrusin EM; Ivanovic I; Kraker AJ; Lee HH; Lunney EA; Ortwine DF; Palmer BD; Quin J; Squire CJ; Thompson AM; Denny WA
    Eur J Med Chem; 2008 Jun; 43(6):1276-96. PubMed ID: 17869387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of compound 584, an Abl kinase inhibitor with lasting effects.
    Puttini M; Redaelli S; Moretti L; Brussolo S; Gunby RH; Mologni L; Marchesi E; Cleris L; Donella-Deana A; Drueckes P; Sala E; Lucchini V; Kubbutat M; Formelli F; Zambon A; Scapozza L; Gambacorti-Passerini C
    Haematologica; 2008 May; 93(5):653-61. PubMed ID: 18367480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines.
    Alberti MJ; Auten EP; Lackey KE; McDonald OB; Wood ER; Preugschat F; Cutler GJ; Kane-Carson L; Liu W; Jung DK
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3778-81. PubMed ID: 15993060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors.
    Verma S; Nagarathnam D; Shao J; Zhang L; Zhao J; Wang Y; Li T; Mull E; Enyedy I; Wang C; Zhu Q; Altieri M; Jordan J; Dang TT; Reddy S
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1973-7. PubMed ID: 15808450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and pharmacological evaluation of thieno[2,3-b]pyridine derivatives as novel c-Src inhibitors.
    Pevet I; Brulé C; Tizot A; Gohier A; Cruzalegui F; Boutin JA; Goldstein S
    Bioorg Med Chem; 2011 Apr; 19(8):2517-28. PubMed ID: 21459579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors.
    Berger DM; Dutia M; Powell D; Floyd MB; Torres N; Mallon R; Wojciechowicz D; Kim S; Feldberg L; Collins K; Chaudhary I
    Bioorg Med Chem; 2008 Oct; 16(20):9202-11. PubMed ID: 18815050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening to successfully identify novel janus kinase 3 inhibitors: a sequential focused screening approach.
    Chen X; Wilson LJ; Malaviya R; Argentieri RL; Yang SM
    J Med Chem; 2008 Nov; 51(21):7015-9. PubMed ID: 18844338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based virtual screening of Src kinase inhibitors.
    Lee K; Kim J; Jeong KW; Lee KW; Lee Y; Song JY; Kim MS; Lee GS; Kim Y
    Bioorg Med Chem; 2009 Apr; 17(8):3152-61. PubMed ID: 19321350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Src kinase activity by 7-[(2,4-dichloro-5-methoxyphenyl)amino]-2-heteroaryl-thieno[3,2-b]pyridine-6-carbonitriles.
    Boschelli DH; Wu B; Barrios Sosa AC; Chen JJ; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4681-4. PubMed ID: 16125383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.